Influvac sub-unit, suspension for injection (influenza vaccine, surface antigen, inactivated) Malta - English - Medicines Authority

influvac sub-unit, suspension for injection (influenza vaccine, surface antigen, inactivated)

mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - a, guangdong, maonan, swl, hong kong, b, washington - suspension for injection in pre-filled syringe - a/guangdong-maonan/swl1536/2019 15 µg a/hong kong/2671/2019 15 µg b/washington/02/2019 15 µg - vaccines

STAMARIL Yellow fever vaccine, live, stabilised   powder for injection vial and diluent syringe Australia - English - Department of Health (Therapeutic Goods Administration)

stamaril yellow fever vaccine, live, stabilised powder for injection vial and diluent syringe

sanofi-aventis australia pty ltd - yellow fever virus, quantity: 1000 pfu e.1000 mouse ld50 - injection, powder for - excipient ingredients: calcium chloride dihydrate; magnesium sulfate heptahydrate; histidine hydrochloride; sodium chloride; dibasic sodium phosphate dihydrate; alanine; sorbitol; potassium chloride; lactose monohydrate; monobasic potassium phosphate; sodium hydroxide - prevention of yellow fever. vaccination is recommended for:,? every individual aged 9 months and over living or travelling through an endemic area with a current or periodic risk of yellow fever transmission. ? non-vaccinated individual moving from an endemic area with a current or periodic risk of yellow fever transmission to a potentially receptive non-endemic area with a current or periodic risk of yellow fever transmission. ? laboratory workers handling potentially infectious materials. in order to be officially recognised, the yellow fever vaccination must be administered in an approved vaccination centre and registered on an international certificate. the validity period of the certificate is established according to international health regulations recommendations and starts 10 days after primary vaccination and immediately after re-vaccination.

Varilrix Vaccine New Zealand - English - Medsafe (Medicines Safety Authority)

varilrix vaccine

glaxosmithkline nz limited - varicella vaccine 2000 pfu (not less than); varicella vaccine 2000 pfu (not less than) - powder for injection with diluent - 2000 pfu - active: varicella vaccine 2000 pfu (not less than) excipient: albumin amino acids lactose monohydrate mannitol sorbitol water for injection active: varicella vaccine 2000 pfu (not less than) excipient: amino acids lactose mannitol sorbitol - varilrix is indicated for active immunisation and prophylaxis against varicella in healthy infants (from the age of 9 months), children, adolescents and adults.

VARIVAX REFRIGERATED varicella virus vaccine live powder for  injection vial with prefilled diluent syringe Australia - English - Department of Health (Therapeutic Goods Administration)

varivax refrigerated varicella virus vaccine live powder for injection vial with prefilled diluent syringe

merck sharp & dohme (australia) pty ltd - live varicella vaccine, quantity: 2700 pfu/ml - injection, powder for - excipient ingredients: monobasic potassium phosphate; potassium chloride; hydrolysed gelatin; sodium chloride; dibasic sodium phosphate; urea; sucrose; monosodium glutamate monohydrate - varivax refrigerated is indicated for vaccination against varicella in healthy individuals 12 months of age and older.,see the australian immunisation handbook for vaccination recommendations and schedule.,groups who would particularly benefit from vaccination include:,? non-immune adults, especially those in at-risk occupations such as health-care workers, teachers and workers in children?s day-care centres.,? non-immune parents of young children.,? non-immune household contacts, both adults and children, of immunocompromised patients with no history of disease.

PROQUAD measles, mumps, rubella, varicella live virus vaccine injection vial with sterile diluent vial composite pack Australia - English - Department of Health (Therapeutic Goods Administration)

proquad measles, mumps, rubella, varicella live virus vaccine injection vial with sterile diluent vial composite pack

merck sharp & dohme (australia) pty ltd - measles virus, quantity: 3 tcid50; rubella virus, quantity: 3 tcid50; mumps virus, quantity: 4.3 tcid50; live varicella vaccine, quantity: 3.99 pfu - injection, powder for - excipient ingredients: dibasic sodium phosphate heptahydrate; monobasic sodium phosphate; sodium bicarbonate; albumin; hydrolysed gelatin; sucrose; phenolsulfonphthalein; monobasic potassium phosphate; neomycin; potassium chloride; urea; sorbitol; dibasic potassium phosphate; monosodium glutamate monohydrate; sodium chloride; glucose monohydrate; magnesium sulfate heptahydrate; ferric nitrate nonahydrate; dibasic sodium phosphate dihydrate; sodium pyruvate; folic acid; calcium pantothenate; inositol; choline chloride; nicotinamide; pyridoxine hydrochloride; thiamine hydrochloride; riboflavine; cystine; tyrosine; arginine; glycine; histidine; isoleucine; leucine; lysine; methionine; phenylalanine; threonine; tryptophan; serine; valine; glutamine; calcium chloride dihydrate; water for injections; ascorbic acid; polysorbate 80; dibasic sodium phosphate; adenine sulfate dihydrate; adenosine triphosphate disodium; adenosine phosphate; cholesterol; deoxyribose; glutathione; guanine hydrochloride monohydrate; sodium hypoxanthine; ribose; sodium acetate; thymine; uracil; sodium xanthine; dl-alanine; arginine hydrochloride; dl-aspartic acid; cysteine hydrochloride; cystine dihydrochloride; dl-glutamic acid; histidine hydrochloride; hydroxyproline; dl-leucine; lysine hydrochloride; dl-methionine; dl-phenylalanine; proline; dl-serine; dl-threonine; dl-tryptophan; tyrosine disodium; dl-valine; biotin; ergocalciferol; menadione; nicotinic acid; aminobenzoic acid; pyridoxal hydrochloride; retinol acetate; dl-alpha-tocopheryl phosphate disodium - proquad is indicated for simultaneous immunisation against measles, mumps, rubella and varicella in individuals 12 months through 12 years of age.

HBvaxPRO vaccine New Zealand - English - Medsafe (Medicines Safety Authority)

hbvaxpro vaccine

merck sharp & dohme (new zealand) limited - hepatitis b vaccine, rdna 10 µg/ml - suspension for injection - 10 mcg/ml - active: hepatitis b vaccine, rdna 10 µg/ml excipient: aluminium as amorphous aluminum hydroxyphosphate sulphate borax formaldehyde potassium thiocyanate sodium chloride water for injection - immunisation against infection caused by all known subtypes of hepatitis b virus. hbvaxpro should also prevent hepatitis d (caused by the delta virus) since hepatitis d does not occur in the absence of hepatitis b infection.

HBvaxPRO vaccine New Zealand - English - Medsafe (Medicines Safety Authority)

hbvaxpro vaccine

merck sharp & dohme (new zealand) limited - hepatitis b vaccine, rdna 40 µg/ml - suspension for injection - 40 mcg/ml - active: hepatitis b vaccine, rdna 40 µg/ml excipient: aluminium as amorphous aluminum hydroxyphosphate sulphate borax formaldehyde potassium thiocyanate sodium chloride water for injection - immunisation against infection caused by all known subtypes of hepatitis b virus. hbvaxpro should also prevent hepatitis d (caused by the delta virus) since hepatitis d does not occur in the absence of hepatitis b infection.

ProQuad New Zealand - English - Medsafe (Medicines Safety Authority)

proquad

merck sharp & dohme (new zealand) limited - measles vaccine 1000 tcid50 (edmonston b strain (3 log per dose)); mumps virus, jeryl-lynn strain 19952 tcid50 (b level (4.3 log per dose)); rubella virus, wistar ra27/3 strain 1000 tcid50 ((3 log per dose) ); varicella vaccine 9772 pfu (oka/merck strain (3.99 log per dose));   - injection with diluent - 0.5 ml - active: measles vaccine 1000 tcid50 (edmonston b strain (3 log per dose)) mumps virus, jeryl-lynn strain 19952 tcid50 (b level (4.3 log per dose)) rubella virus, wistar ra27/3 strain 1000 tcid50 ((3 log per dose) ) varicella vaccine 9772 pfu (oka/merck strain (3.99 log per dose))   excipient: dibasic potassium phosphate dibasic sodium phosphate gelatin minimum essential medium eagle medium 199 monosodium glutamate phenolsulfonphthalein potassium chloride sodium bicarbonate sodium chloride sorbitol sucrose urea water for injection - proquad is indicated for vaccination against measles, mumps, rubella, and varicella in individuals 12 months through 12 years of age.

Priorix - Powder and solvent for solution for injection in a pre-filled syringeMeasles, Mumps and Rubella vaccine (live) Ireland - English - HPRA (Health Products Regulatory Authority)

priorix - powder and solvent for solution for injection in a pre-filled syringemeasles, mumps and rubella vaccine (live)

glaxosmithkline (ireland) limited - measles virus - schwarz strain live attenuated; mumps vaccine rit 4385 live attenuated; rubella virus (ra 27/3 strain) - powder and solvent for solution for injection in pre-filled syringe - 0 percent - measles vaccines; measles, combinations with mumps and rubella, live attenuated

RabipurPowder and solvent for solution for injection Rabies vaccine (inactivated) Ireland - English - HPRA (Health Products Regulatory Authority)

rabipurpowder and solvent for solution for injection rabies vaccine (inactivated)

gsk vaccines gmbh - inactivated rabies virus - powder and solvent for solution for injection - 2.5 international unit(s)/millilitre - rabies vaccines; rabies, inactivated, whole virus